Skip to main content

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?

September 17, 2025

HMP · Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?

Welcome to Schizophrenia Knowledge Base

This website is intended for healthcare professionals in the United States.

Yes, I am a US healthcare professional
No, I am not a US healthcare professional

Greg Mattingly, MD examines safer alternatives and their limitations.

Related Content

Can Anticholinergic Medications Make Movement Disorders Worse?
Why Should We Deprescribe Anticholinergics?
Assessing Anticholinergic Burden
Anticholinergic Misuse: Can These Medications Be Addictive?
Understanding the Cholinergic System
What’s the Role of Amantadine in Anticholinergic Deprescription?
Treatment Options and Managing Side Effects in Schizophrenia
© 2025 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use Cookie Policy